Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

9.55
+0.27002.91%
Post-market: 9.600.0500+0.52%19:30 EDT
Volume:2.33M
Turnover:22.54M
Market Cap:1.64B
PE:-11.94
High:9.90
Open:9.56
Low:9.50
Close:9.28
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:0.82
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:6.66
PE(LYR):-11.34

Loading ...

Absci Prices 13,495,277-share Follow-on Offering at $7.41 Per Share to Raise $100 Million

Reuters
·
Jun 24

Absci Corp - Prices Underwritten Offering of 13.5 Mln Shares at $7.41 Per Share

THOMSON REUTERS
·
Jun 24

Absci Corp - Eli Lilly & Company and Others Participate in $100 Mln Absci Offering

THOMSON REUTERS
·
Jun 24

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

THOMSON REUTERS
·
Jun 24

Absci Reports Positive Interim Phase 1 Data for Abs-201 Antibody in Headline Trial

Reuters
·
Jun 24

Absci Corp - Abs-201 Half-life Estimated at Least 65 Days Supports Infrequent Dosing

THOMSON REUTERS
·
Jun 24

Absci Corp - Abs-201 Well Tolerated with Favorable Safety Data in All Sad Cohorts

THOMSON REUTERS
·
Jun 24

Absci Announces Positive Interim Phase 1 Data from the Headline™ Trial of Abs-201, a Novel Antibody Targeting the Prolactin Receptor (prlr)

THOMSON REUTERS
·
Jun 24

Absci Corp - First Multiple Ascending Dose Cohort of Abs-201 Initiated in Aga Participants

THOMSON REUTERS
·
Jun 24

Absci Corp: Full Proof-of-concept Data Anticipated in Early 2027

THOMSON REUTERS
·
Jun 24

Absci Corp - no Serious Adverse Events Reported in Abs-201 Phase 1 Interim Data

THOMSON REUTERS
·
Jun 24

Absci Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 15

Nu, Broadcom, UNH, AbSci, TMC Trending With Analysts

TIPRANKS
·
Jun 06

Absci Shares Rise After Leerink Partners Initiates Coverage at Outperform

MT Newswires Live
·
Jun 05

Absci Initiated at Outperform by Leerink Partners

Dow Jones
·
Jun 04

Absci initiated with an Outperform at Leerink

TIPRANKS
·
Jun 04

Leerink Partners Initiates Absci at Outperform With $12 Price Target

MT Newswires Live
·
Jun 04

Absci Corp : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $12

THOMSON REUTERS
·
Jun 04

U.S. RESEARCH ROUNDUP-Broadcom, CrowdStrike, Home Depot

Reuters
·
Jun 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), AbSci (ABSI) and Travere Therapeutics (TVTX)

TIPRANKS
·
Jun 03